Literature DB >> 22695425

4F, apolipoprotein AI mimetic peptide, attenuates acute lung injury and improves survival in endotoxemic rats.

Woon Yong Kwon1, Gil Joon Suh, Kyung Su Kim, Young Ho Kwak, Kyuseok Kim.   

Abstract

BACKGROUND: 4F, apolipoprotein AI mimetic peptide, mimics anti-inflammatory properties of high-density lipoprotein (HDL). The aim of this study was to investigate whether 4F attenuates acute lung injury and improves survival in endotoxemic rats and to determine whether the therapeutic benefits of 4F are associated with the stimulation of sphingosine-1-phosphate receptor 1 (S1P1), the activation of Akt, the down-regulation of the nuclear factor-κB (NF-κB) pathway, and the suppression of cell adhesion molecules.
METHODS: To induce endotoxemia in rats, lipopolysaccharide (LPS, 10 mg/kg) was injected into a tail vein and 10 minutes later, vehicle or 4F (10 mg/kg) was administered intraperitoneally, respectively. We observed the survival of subjects for 72 hours. At 6-hour post-LPS, we killed animals and measured S1P1 expression, phosphorylated Akt/Akt ratio, cytoplasmic phosphorylated inhibitor κB-α/inhibitor κB-α ratio, nuclear NF-κB p65 expression and DNA-binding activity, endothelial leukocyte adhesion molecule-1 (E-selectin) and intercellular adhesion molecule-1 expression, myeloperoxidase activity, and histologic damages in lung tissues. We also measured serum HDL cholesterol level.
RESULTS: 4F improved survival in endotoxemic rats. 4F restored LPS-induced diminution of serum HDL cholesterol level and increased lung S1P1 expression and phosphorylated Akt/Akt ratio in LPS-treated rats. Furthermore, 4F suppressed inhibitor κB-α degradation, NF-κB activation, E-selectin and intercellular adhesion molecule-1 expression, and myeloperoxidase activity, and attenuated histologic damages in lung tissues.
CONCLUSIONS: 4F attenuated acute lung injury and improved survival in endotoxemic rats. The therapeutic benefits of 4F were found to be associated with the stimulation of S1P1, the activation of Akt, the down-regulation of the NF-κB pathway, and the suppression of cell adhesion molecules.
Copyright © 2012 by Lippincott Williams & Wilkins

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22695425     DOI: 10.1097/TA.0b013e3182493ab4

Source DB:  PubMed          Journal:  J Trauma Acute Care Surg        ISSN: 2163-0755            Impact factor:   3.313


  15 in total

1.  Exploring the Predictive Ability of Dysfunctional High-Density Lipoprotein for Adverse Outcomes in Emergency Department Patients with Sepsis: A Preliminary Investigation.

Authors:  Faheem W Guirgis; Sunita Dodani; Lyle Moldawer; Christiaan Leeuwenburgh; Jennifer Bowman; Colleen Kalynych; Alan E Jones; Srinivasa T Reddy; Frederick A Moore
Journal:  Shock       Date:  2017-11       Impact factor: 3.454

2.  HDL and Sepsis.

Authors:  Huanhuan Cao; Wei Huang
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  HDL and Therapy.

Authors:  Ke Li; Xianwei Xie; Yansong Guo
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 4.  The Many Roles of Cholesterol in Sepsis: A Review.

Authors:  Daniel A Hofmaenner; Anna Kleyman; Adrian Press; Michael Bauer; Mervyn Singer
Journal:  Am J Respir Crit Care Med       Date:  2022-02-15       Impact factor: 30.528

Review 5.  Apolipoprotein A-I mimetics.

Authors:  Srinivasa T Reddy; Mohamad Navab; Gattadahalli M Anantharamaiah; Alan M Fogelman
Journal:  Curr Opin Lipidol       Date:  2014-08       Impact factor: 4.776

Review 6.  Emerging Roles of Apolipoprotein E and Apolipoprotein A-I in the Pathogenesis and Treatment of Lung Disease.

Authors:  Xianglan Yao; Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Stewart J Levine
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

7.  L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.

Authors:  Oleg F Sharifov; Xin Xu; Amit Gaggar; Edlue M Tabengwa; C Roger White; Mayakonda N Palgunachari; G M Anantharamaiah; Himanshu Gupta
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

Review 8.  High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease.

Authors:  Elizabeth M Gordon; Debbie M Figueroa; Amisha V Barochia; Xianglan Yao; Stewart J Levine
Journal:  Front Pharmacol       Date:  2016-09-21       Impact factor: 5.810

9.  Admission levels of high-density lipoprotein and apolipoprotein A-1 are associated with the neurologic outcome in patients with out-of-hospital cardiac arrest.

Authors:  Yong Soo Son; Kyung Su Kim; Gil Joon Suh; Woon Yong Kwon; Min Ji Park; Jung In Ko; Taegyun Kim
Journal:  Clin Exp Emerg Med       Date:  2017-12-30

10.  Anti-inflammatory mechanisms of apolipoprotein A-I mimetic peptide in acute respiratory distress syndrome secondary to sepsis.

Authors:  Oleg F Sharifov; Xin Xu; Amit Gaggar; William E Grizzle; Vinod K Mishra; Jaideep Honavar; Silvio H Litovsky; Mayakonda N Palgunachari; C Roger White; G M Anantharamaiah; Himanshu Gupta
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.